Biomanufacturing: Advancing health sciences industry in Canada
Resources for Canadian businesses
Managing your business during COVID-19
Biomanufacturing in Canada
Ensuring access to critical vaccines, therapeutics and other health products is a priority for the Government of Canada. At the outset of the COVID-19 pandemic, the Government of Canada took early and decisive action to strengthen Canada's biomanufacturing capacity to protect Canadians. We continue to invest in domestic biomanufacturing capabilities and secure medical countermeasures.
How to get involved
Innovation, Science and Economic Development Canada, in partnership with Health Canada, and the Public Health Agency of Canada are engaging with stakeholders on the elements of a robust domestic biomanufacturing sector. Give us your input on the prospective expansion of biomanufacturing capacity and related enhancements to the life sciences ecosystem in Canada.
Join the consultation today!
Find out why domestic biomanufacturing is important for Canada
See what it takes to make a vaccine
Find out about current biomanufacturing projects in Canada
Advancing the health sciences industry
Since March 2020, the government has taken a multifaceted approach including over $1 billion in advance purchase agreements to secure a domestic supply of up to 429 million doses of promising COVID-19 vaccines. The Government of Canada has also committed $792 million through the Strategic Innovation Fund (SIF), to support research and development, clinical trials, and the manufacturing of vaccines and therapeutic drugs to fight COVID-19.
Innovation, Science, and Economic Development Canada – in partnership with Health Canada, the Public Health Agency of Canada, and partner departments and agencies – is actively engaging with stakeholders. This engagement is to explore ways that the Government of Canada can support future pandemic preparedness, including through vaccine and therapeutic manufacturing in Canada.
COVID-19 health product industry
Information for health product manufacturers and distributors in relation to COVID-19
Microbial fermentation pilot plant
See how the NRC helps its collaborators optimize and scale up production processes
Cell culture pilot plant
See how the NRC helps its collaborators scale up cell culture processes
Do you have questions? Contact us
Innovation, Science and Economic Development Canada
Thank you for your feedback
- Date modified: